Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model. 2002

Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
Research Institute, Daiichi Fine Chemical Co., Ltd., 530 Chokeiji, Takaoka, Toyama 933-8511, Japan.

A new series of succinate-based dual inhibitors against matrix metalloproteinases (MMPs) and tumor necrosis factor alpha converting enzyme (TACE) possessing highly-water solubility was designed, synthesized, and evaluated for enzyme inhibition. Incorporating of acidic or basic functional groups at the P(2)' position afforded sufficient water solubility without significant loss of inhibitory potencies. Compound 18e, which had a guanidino group at the P(2)' position as the basic functional group, exhibited broad inhibition against target enzymes for a relatively long period in rat plasma (beta t(1/2); 2.0h) after sc administration when compared with compounds possessing acidic functional groups (18a and 18b). Consequently, the representative compound 18e together with compound 18b, Marimastat and Trocade were evaluated in the rat adjuvant-induced arthritis model, a model of chronic cartilage destruction. It is concluded that the newly synthesized highly water-soluble compound 18e showed significant activity in suppressing hindpaw swelling and the bone destruction with a minimal administration period (days 3-7).

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000072198 ADAM17 Protein A disintegrin and metalloproteinase domain-containing protein that cleaves the membrane-bound precursor of TUMOR NECROSIS FACTOR-ALPHA to its mature form. It cleaves several other CELL SURFACE PROTEINS, including INTERLEUKIN-1 RECEPTOR TYPE II; TRANSFORMING GROWTH FACTOR ALPHA; L-SELECTIN; MUCIN-1; and AMYLOID BETA-PROTEIN PRECURSOR. It can also function as an activator of the Notch signaling pathway by mediating the cleavage of NOTCH RECEPTORS. ADAM-17,ADAM-17 Protein,CD156b Antigen,Disintegrin and Metalloproteinase Domain-Containing Protein 17,TACA (Enzyme),TACE (Enzyme),TNF-alpha Convertase,TNF-alpha Converting Enzyme,Tumor Necrosis Factor Alpha Convertase,Tumor Necrosis Factor-alpha Convertase,Tumor Necrosis Factor-alpha Converting Enzyme,ADAM 17 Protein,Antigen, CD156b,Convertase, TNF-alpha,Disintegrin and Metalloproteinase Domain Containing Protein 17,TNF alpha Convertase,TNF alpha Converting Enzyme,Tumor Necrosis Factor alpha Converting Enzyme
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides

Related Publications

Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
January 2001, Methods in molecular medicine,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
October 1995, Acta orthopaedica Scandinavica. Supplementum,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
January 1999, Anticancer research,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
December 2005, Histochemistry and cell biology,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
December 2010, European journal of medicinal chemistry,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
December 2011, The European journal of neuroscience,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
August 1992, American journal of respiratory cell and molecular biology,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
January 2012, Postepy biochemii,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
October 2000, The British journal of ophthalmology,
Tetsunori Fujisawa, and Katsuhiro Igeta, and Shinjiro Odake, and Yasuo Morita, and Junko Yasuda, and Tadanori Morikawa
May 2005, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!